Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
MEI Pharma (MEIP)
NASDAQ:MEIP
Holding MEIP?
Track your performance easily
MEIP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.61 - $7.87
Previous Close$3.04
Volume63.08K
Average Volume (3M)42.20K
Market Cap
$20.39M
Enterprise Value-$17.96M
Total Cash (Recent Filing)$38.34M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)1.1
Beta0.41
Next Earnings
Nov 07, 2024EPS EstimateN/A
Last Dividend Ex-Date
Nov 16, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)2.67
Shares Outstanding6,662,857
10 Day Avg. Volume186,600
30 Day Avg. Volume42,204
Standard Deviation0.22
R-Squared0.04
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.61
Price to Sales (P/S)0.31
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.27
Enterprise Value/Gross Profit-0.27
Enterprise Value/Ebitda-1.03
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
MEI Pharma News
PremiumCompany Announcements
MEI Pharma Explores Strategic Shifts, Leadership Changes
PremiumCompany Announcements
MEI Pharma Explores Strategic Options, Halts Drug Development
Ownership Overview
1.20% Insiders
6.96% Mutual Funds
0.11% Other Institutional Investors
87.40% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
MEIP FAQ
What was MEI Pharma’s price range in the past 12 months?
MEI Pharma lowest stock price was $2.61 and its highest was $7.87 in the past 12 months.
What is MEI Pharma’s market cap?
Currently, no data Available
When is MEI Pharma’s upcoming earnings report date?
MEI Pharma’s upcoming earnings report date is Nov 07, 2024 which is 3 days ago.
How were MEI Pharma’s earnings last quarter?
MEI Pharma released its earnings results on Sep 19, 2024. The company reported -$2.76 earnings per share for the quarter, missing the consensus estimate of -$1.407 by -$1.353.
Is MEI Pharma overvalued?
According to Wall Street analysts MEI Pharma’s price is currently Overvalued.
Does MEI Pharma pay dividends?
MEI Pharma pays a Notavailable dividend of $1.75 which represents an annual dividend yield of N/A. See more information on MEI Pharma dividends here
What is MEI Pharma’s EPS estimate?
MEI Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MEI Pharma have?
MEI Pharma has 6,662,857 shares outstanding.
What happened to MEI Pharma’s price movement after its last earnings report?
MEI Pharma reported an EPS of -$2.76 in its last earnings report, missing expectations of -$1.407. Following the earnings report the stock price went down -5.096%.
Which hedge fund is a major shareholder of MEI Pharma?
Among the largest hedge funds holding MEI Pharma’s share is Carlson Capital LP. It holds MEI Pharma’s shares valued at N/A.
---
MEI Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
MEIP Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 64.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.0%
Last 30 Days ▲ 6.4%
Last 30 Days ▲ 6.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.02%
12-Months-Change
Fundamentals
Return on Equity
61.68%
Trailing 12-Months
Asset Growth
-65.75%
Trailing 12-Months
Company Description
MEI Pharma
MEI Pharma, Inc. engages in the clinical development of therapies for cancer. Its drug candidates includes Pracinostat, an oral HDAC inhibitor that is being developed in combination with azacitidine for the treatment of acute myeloid leukemia and myelodysplastic syndrome. Its pipeline also consists of ME-401, an oral PI3K delta inhibitor; Voruciclib, an oral CDK inhibitor; and ME-344, a mitochondrial inhibitor. The company was founded on December 1, 2000 and is headquartered in San Diego, CA.
---
MEIP Earnings Call
Q4 2023
0:00 / 0:00
---
MEIP Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Oncternal Therapeutics
―
TRACON Pharmaceuticals
―
Karyopharm Therapeutics
―
ESSA Pharma
―
---